Kewaunee Scientific Corporation KEQU Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 28.5%-0.4pp | 28.9%-0.2pp | 29.1%-0.3pp | 29.4%+0.7pp | 28.6%+1.6pp | |
| Operating margin | 5.9%-1.0pp | 7%+0.1pp | 6.9%-0.7pp | 7.6%+0.2pp | 7.4%+0.7pp | |
| Net margin | 3.4%-0.4pp | 3.9%-0.3pp | 4.1%-0.6pp | 4.7%-0.1pp | 4.7%-3.2pp | |
| EBITDA margin | 8.2%-0.8pp | 9%+0.2pp | 8.8%-0.7pp | 9.5%+0.2pp | 9.4%+0.7pp | |
| Free cash flow margin | 5.2%-1.4pp | 6.6%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 13.8%-3.0pp | 16.9%-1.3pp | 18.2%-1.8pp | 20%+0.9pp | 19.1%-14.4pp | |
| Return on assets | 5.2%-0.9pp | 6.1%-1.2pp | 7.3%-0.3pp | 7.6%+0.6pp | 6.9%-4.2pp | |
| Return on invested capital | 15.8%-1.5pp | 17.3%-8.4pp | 25.7%-2.4pp | 28.2%+3.0pp | 25.1%-4.1pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×-0.1× | 1.6×-0.2× | 1.8×+0.1× | 1.6×+0.2× | 1.5×+0.1× | |
| Inventory turnover | 6.4×0.0× | 6.3×-1.1× | 7.5×+0.6× | 6.9×+0.4× | 6.4×+0.4× | |
| Liquidity | ||||||
| Current ratio | 2.2×+0.1× | 2.1×-0.4× | 2.5×+0.2× | 2.3×+0.1× | 2.2×0.0× | |
| Quick ratio | 1.5×+0.1× | 1.4×-0.3× | 1.7×+0.1× | 1.6×0.0× | 1.6×+0.1× | |
| Cash ratio | 0.2×0.0× | 0.2×-0.1× | 0.3×-0.1× | 0.4×+0.1× | 0.3×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×-0.1× | 0.4×+0.1× | 0.3×0.0× | 0.4×0.0× | 0.4×-0.1× | |
| Debt-to-assets | 0.1×0.0× | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | 0.7×-0.1× | 0.8×+0.4× | 0.4×+0.2× | 0.1×-0.1× | 0.3×-0.5× | |
| Interest coverage | 4.3×-0.2× | 4.6×+0.1× | 4.5×-0.8× | 5.3×-0.3× | 5.5×-0.1× | |
| Per Share | ||||||
| Book value per share | $25.05+5.7% | $23.69+1.4% | $23.36+3.2% | $22.64+4.6% | $21.64+6.6% | |
| Valuation | ||||||
| Market capitalization | $101.96M-34.8% | $113.34M-5.4% | $119.84M-26.5% | $163.09M+66.7% | $97.81M-47.0% | |
| Enterprise value | $117.3M-28.0% | $134.06M+3.8% | $129.16M-22.5% | $166.71M+59.7% | $104.36M-47.8% | |
| Price / earnings | 10.6×-3.1× | 10.2×0.0× | 10.2×-3.0× | 13.3×+4.7× | 8.6×-1.9× | |
| Price / sales | 0.4×-0.3× | 0.4×0.0× | 0.4×-0.2× | 0.6×+0.2× | 0.4×-0.4× | |
| Price / book | 1.4×-1.1× | 1.6×-0.1× | 1.7×-0.7× | 2.4×+0.9× | 1.5×-1.5× | |
| EV / EBITDA | 5.1×-2.1× | 5.2×0.0× | 5.1×-1.5× | 6.6×+2.0× | 4.6×-5.8× | |
| EV / sales | 0.4×-0.3× | 0.5×0.0× | 0.5×-0.2× | 0.6×+0.2× | 0.4×-0.5× | |
| Free cash flow yield | 14.4%— | 16.8%— | —— | —— | —— | |
| Earnings yield | 9.4%+2.1pp | 9.8%0.0pp | 9.8%+2.3pp | 7.5%-4.1pp | 11.7%+2.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kewaunee Scientific Corporation's profit margins?
- Kewaunee Scientific Corporation (KEQU) runs a 28.5% gross margin and a 5.9% operating margin, with a 3.4% net margin.
- Where do Kewaunee Scientific Corporation's ratios come from?
- Every ratio is computed from Kewaunee Scientific Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
